Search clinical trials for: venlafaxine ER

Total 371720 results

H. Lundbeck A/S

Completed

Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults

Major Depressive Disorder
National Institute of Mental Health (NIMH)

Completed

Combining Medications to Enhance Depression Outcomes (CO-MED)

Major Depressive Disorder

United States
US Department of Veterans Affairs

Completed

Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury

Pain | Neuropathic Pain | Spinal Cord Injuries

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder

Major Depressive Disorder

China
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Optimizing Electroconvulsive Therapy for Depression

Depressive Disorder | Depression | Bipolar Disorder

United States
Club rTMS et Psychiatrie
Wyeth is now a wholly owned subsidiary of Pfizer; Ministry of Health, France

Completed

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Unipolar Depression

France, Monaco
Duke University
National Institutes of Health (NIH)

Completed

Treatment of Mood and Marriage Study (TOMMS)

Major Depressive Disorder | Partner Relational Disorder (V61.10)

United States
Novartis

Completed

Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma

Asthma

Germany, Belgium
Janssen Research & Development, LLC

Terminated

A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder

Depression

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects

Healthy

United States
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Antidepressant Medication Plus Donepezil for Treating Late-life Depression

Depression | Dementia

United States
Shanghai Mental Health Center

Unknown

Algorithm Guided Treatment Strategies for Major Depressive Disorder (AGTs-MDD)

Major Depressive Disorder

China
University of Rochester
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Study of Antidepressants in Parkinson's Disease (SAD-PD)

Depression | Parkinson Disease

United States, Puerto Rico, Canada
National Center for Complementary and Integrative...

Terminated

Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)

Anxiety Disorders
Tirat Carmel Mental Health Center
University of Michigan; The Nazareth Hospital, Israel; Ariel University

Completed

Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression

Major Depression

Israel
AstraZeneca

Completed

Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients (RUBY)

Major Depressive Disorder | Treatment Resistant Depression

Bulgaria, Italy, United Kingdom, Germany, Hungary, Romania, Austria, Belgium, Denmark, Portugal, Slovakia, Australia, Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program

Depressive Disorder, Major

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients

Major Depressive Disorder

China
Sunovion

Completed

A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia

Insomnia | Major Depressive Disorder

France, Poland, Russian Federation, United Kingdom, Austria, Hungary, Croatia, Romania, Serbia, Ukraine
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions

Healthy

India
Korea University
Taiwan Otsuka Pharm. Co., Ltd; Korea OIAA

Unknown

Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder

Major Depressive Disorder

Korea, Republic of, Taiwan
St. Joseph's Healthcare Hamilton

Unknown

Electroencephalography (EEG) Signal Processing (EEG-SP)

Major Depressive Disorder

Canada
Uppsala University
University of Copenhagen

Completed

Population Pharmacokinetic-pharmacodynamic (PK-PD) Modeling of Co-administered Gabapentin in Neuropathic Pain

Post-traumatic Neuropathic Pain

Sweden
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions

Healthy
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions

Healthy

India
Teva Pharmaceuticals USA

Completed

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

Healthy

Canada
University Health Network, Toronto

Completed

Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression

Bipolar Disorder

Canada
AstraZeneca

Completed

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder (ONYX)

Major Depressive Disorder

Sweden, Czech Republic, France, Germany, Poland, Romania, Finland, Norway, Belgium, Canada, Australia, South Africa
H. Lundbeck A/S

Terminated

Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder

Major Depressive Disorder

Canada
National Cheng-Kung University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)

Unknown

Pharmacogenomics Studies of Antidepressants

Major Depressive Disorder | Pharmacogenetics | Antidepressive Agents | Fluoxetine | Venlafaxine

Taiwan
Actavis Inc.

Completed

A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed Conditions

Healthy

Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects

Healthy

United States
Massachusetts General Hospital

Completed

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Breast Cancer | Hot Flashes | Sleep Disorders

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder

Panic Disorders

Brazil
Teva Pharmaceuticals USA

Completed

Venlafaxine 25 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients

Anxiety | Depressive Syndrome
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder

Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Venlafaxine ER in Adults With Panic Disorder

Panic Disorder
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Venlafaxine ER in Recurrent Depression

Recurrence | Depressive Disorder, Major
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Venlafaxine ER in Patients With Panic Disorder

Panic Disorder
University of California, Los Angeles
Wyeth is now a wholly owned subsidiary of Pfizer; Medtronic - MITG

Completed

Electroencephalography (EEG) Biomarkers of Response in Depression

Major Depressive Disorder

United States
Centre for Addiction and Mental Health
Ontario Mental Health Foundation

Completed

Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression

Depression | Major Depressive Disorder

Canada
Massachusetts General Hospital
Medtronic - MITG

Completed

Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression

Major Depressive Disorder
National Institute of Mental Health (NIMH)

Completed

Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression

Depressive Disorder | Bipolar Disorder

United States
National Institute of Mental Health (NIMH)

Completed

Effects of Drugs on Cerebral Blood Flow in Patients With Mood Disorders

Mood Disorders | Healthy

United States
University of Washington
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Single-Blind Placebo Run-In Study of Venlafaxine for Activity-Limiting Osteoarthritis Pain

Pain | Osteoarthritis
Adams Respiratory Therapeutics

Completed

Phase 4 Study - Mucinex D as Adjunct Therapy

Bronchitis | Acute Respiratory Infection | Rhinosinusitis

United States
Hillerod Hospital, Denmark
Wyeth is now a wholly owned subsidiary of Pfizer; Tvergaards Foundation

Terminated

Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression

Major Depression

Denmark
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

Social Anxiety Disorder

Search clinical trials for: venlafaxine ER

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations